Diagnostic and Therapeutic Implications of Histone Epigenetic Modulators in Breast Cancer

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Breast cancer treatment has advanced with targeted therapies based on subtype-specific biology.
• Resistance to targeted therapy, both intrinsic and acquired, remains a significant challenge in cancer care.
• Epigenetic alterations are implicated in both cancer development and therapeutic resistance across various cancers.

Purpose of the Study:

• To review the current landscape of targetable epigenetic histone modifications in breast cancer.
• To discuss the diagnostic and therapeutic implications of these epigenetic modifications.
• To highlight the potential of targeting epigenetic proteins for overcoming treatment resistance.

Main Methods:

• Literature review of current research on epigenetic histone modifications in breast cancer.
• Analysis of studies investigating epigenetic-mediated resistance to targeted therapies.
• Examination of the role of epigenetic modifiers in tumorigenesis and treatment response.

Main Results:

• Epigenetic modifications play a crucial role in the development of intrinsic and acquired resistance to targeted breast cancer therapies.
• Altered expression of epigenetic modifiers is linked to breast cancer initiation and progression.
• Epigenetic modifications are reversible, making epigenetic proteins attractive therapeutic targets.

Conclusions:

• Targeting epigenetic histone modifications presents a promising strategy for improving breast cancer treatment outcomes.
• Understanding epigenetic mechanisms can help overcome resistance to current targeted therapies.
• Epigenetic therapies hold potential for both initial treatment and managing relapsed or resistant breast cancer.